Treatment effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in people underrepresented from the ontarget trial: Analysis of routinely collected data using trial replication methods (2022) Baptiste PJ, Wong A, Schultze A, Cunnington M, Mann J, Clase C, Leyrat C, et al. Conference contribution Kidsafe-improving medication safety for children and adolescents: Implementation and evaluation of a new form of care (2022) Toni I, Koenig J, Makosi DM, Urschitz MS, Rascher W, Neubert A Conference contribution Off-label use of drugs in pediatric (specialized) outpatient clinics-What has changed between 2009 and 2019? (2022) Toni I, Hupfer J, Gerber C, Rascher W, Neubert A Conference contribution Sex and the risk of acute reduction in kidney function after renin-angiotensin blockade: Parallel analyses of a primary care cohort and two randomised trials (2020) Wong A, Gao P, Mansfield K, Bhaskaran K, Carrero JJ, Sinnott SJ, Nitsch D, et al. Conference contribution Prevalence of chronic drug use in pediatrics: Comprehensive overview based on German claims data (2020) Scholle O, Neubert A, Riedel O, Toni I, Haug U Conference contribution Contact allergy to ingredients of topical medications: results of the European Surveillance System on Contact Allergies (ESSCA), 2009-2012 (2016) Uter W, Spiewak R, Cooper SM, Wilkinson M, Sanchez Perez J, Schnuch A, Schuttelaar ML Journal article Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study (2015) Gillespie IA, Macdougall IC, Richards S, Jones V, Marcelli D, Froissart M, Eckardt KU Journal article Adverse drug events in patients admitted to an emergency department: an analysis of direct costs (2015) Meier F, Maas R, Sonst A, Patapovas A, Müller F, Plank-Kiegele B, Pfistermeister B, et al. Journal article, Original article Diclofenac: increase of myocardial infarctions at low doses? (2014) Brune K Journal article